Echocardiographic phenotype and prognosis in transthyretin cardiac amyloidosis.

doi:10.1093/eurheartj/ehz905

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

Echocardiographic phenotype and prognosis in transthyretin cardiac amyloidosis.

European heart journal - 7 Apr 2020

Chacko Liza, Martone Raffaele, Bandera Francesco, Lane Thirusha, Martinez-Naharro Ana, Boldrini Michele, Rezk Tamer, Whelan Carol, Quarta Cristina, Rowczenio Dorota, Gilbertson Janet A, Wongwarawipat Tanakal, Lachmann Helen, Wechalekar Ashutosh, Sachchithanantham Sajitha, Mahmood Shameem, Marcucci Rossella, Knight Daniel, Hutt David, Moon James, Petrie Aviva, Cappelli Francesco, Guazzi Marco, Hawkins Philip N, Gillmore Julian D, Fontana Marianna

Abstract excerpt

AIMS: Transthyretin amyloidosis cardiomyopathy (ATTR-CM) is an increasingly recognized cause of heart failure. We sought to characterize the structural and functional echocardiographic phenotype across the spectrum of wild-type (wtATTR-CM) and hereditary (hATTR-CM) transthyretin cardiomyopathy and the echocardiographic features predicting prognosis. METHODS AND RESULTS: We studied 1240 patients with ATTR-CM who...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Amyloid Neuropathies, Familial

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Amyloidosis: Diagnosis, Treatment, Outcomes

Share to Cardiomyopathies

Share to Echocardiography

Share to Parathyroid Disorders and Treatments

Share to Phenotype

Share to Prealbumin

Share to Prognosis

Source

Open in PubMed

Identifiers

PMID: 31950987
DOI: 10.1093/eurheartj/ehz905

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Echocardiographic phenotype and prognosis in transthyretin cardiac amyloidosis.PMID 31950987Read ↗

Diversity of heart failure phenotypes in transthyretin amyloid cardiomyopathy. More than just heart failure with preserved ejection fraction.Semantic proximity Read ↗

Genotype, echocardiography, and survival in familial transthyretin amyloidosis.Semantic proximity Read ↗

Transthyretin cardiac amyloidosis in continental Western Europe: an insight through the Transthyretin Amyloidosis Outcomes Survey (THAOS)Semantic proximity Read ↗

Cardiac transthyretin amyloidosis.Semantic proximity Read ↗

Phenotype and prognostic factors in geriatric and non-geriatric patients with transthyretin cardiomyopathy.Semantic proximity Read ↗

Transthyretin cardiac amyloid: Broad heart failure phenotypic spectrum and implications for diagnosis.Semantic proximity Read ↗

Unveiling transthyretin cardiac amyloidosis and its predictors among elderly patients with severe aortic stenosis undergoing transcatheter aortic valve replacement.Semantic proximity Read ↗

Prevalence, Characteristics and Outcomes of Older Patients with Hereditary Versus Wild-Type Transthyretin Amyloid CardiomyopathySemantic proximity Read ↗

Prospective evaluation of the morbidity and mortality of wild-type and V122I mutant transthyretin amyloid cardiomyopathy: the Transthyretin Amyloidosis Cardiac Study (TRACS).Semantic proximity Read ↗

Elevated filling pressures but rare restrictive physiology in transthyretin amyloid cardiomyopathy: genotype-specific patterns and the role of left atrial strain.Semantic proximity Read ↗

ATTR Epidemiology, Genetics, and Prognostic FactorsSemantic proximity Read ↗

Echocardiographic phenotype in severe aortic stenosis with and without transthyretin cardiac amyloidosis: the AMY-TAVI study.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.